Recovery Time in Thai Patients With Upper or Lower Respiratory Tract Infections Treated With Klacid MR
|ClinicalTrials.gov Identifier: NCT01076153|
Recruitment Status : Completed
First Posted : February 26, 2010
Results First Posted : June 29, 2011
Last Update Posted : July 12, 2011
|Condition or disease||Intervention/treatment|
|Respiratory Tract Infection||Drug: Clarithromycin (Klacid® MR)|
|Study Type :||Observational|
|Actual Enrollment :||760 participants|
|Official Title:||A Multi-center, Post-Marketing Observational Study to Identify the Recovery Time in Patients With Upper or Lower Respiratory Tract Infections Treated With Klacid MR|
|Study Start Date :||December 2008|
|Actual Primary Completion Date :||April 2010|
|Actual Study Completion Date :||April 2010|
Patients with respiratory tract infection
Thai patients with upper or lower respiratory tract infections on Klacid MR.
Drug: Clarithromycin (Klacid® MR)
Klacid MR 500mg (clarithromycin)
- Average Time From Baseline to Recovery From Cough and Other Symptoms [ Time Frame: Baseline to 14 days ]Study participants were seen at an initial visit (baseline) and received Klacid treatment for 5 to 14 days. A medical appointment (visit or phone call) was made 6 to 14 days after the first visit. Participants' symptoms were rated using one of the following categories: resolved, improved, not changed, or worse. Associated dates were also recorded. Symptoms included, but were not limited to, cough, fever, and sore throat. Recovery was defined as the disappearance of all signs and symptoms of infection.
- Number and Type of Adverse Events [ Time Frame: Baseline to 14 days ]Adverse events were collected during the course of the study up to 30 days or 5 half-lives following the last dose of Klacid. The number of participants experiencing a serious or non-serious adverse event is summarized. See the Reported Adverse Event section for details.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01076153
|Study Director:||Savary Om, M.D.||Abbott|